Evidence map›Paper›PMID 38652590›Full record

ArticleRheumatology (Oxford, England)2025

Major cardiovascular events in patients with cardiovascular monosodium urate deposits in atherosclerotic plaques.

Julia Held, Christoph Schwabl, David Haschka, Sarah Maier, Gudrun Feuchtner, Gerlig Widmann, Christina Duftner, Günter Weiss, Andrea Klauser

Abstract read
In one paragraph

Article in Rheumatology (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Correlation between hyperuricemia and coronary artery calcification.The Journal of international medical research · 2026
    Review
  4. Review
  5. Gout, Uric Acid, and Coronary Artery Disease.Journal of atherosclerosis and thrombosis · 2025
    Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Julia HeldDepartment of Internal Medicine II, Medical University Innsbruck, Innsbruck, Austria.
Christoph SchwablDepartment of Radiology, Medical University Innsbruck, Innsbruck, Austria.
David HaschkaDepartment of Internal Medicine II, Medical University Innsbruck, Innsbruck, Austria.ORCID 0000-0001-8028-1030
Sarah MaierInstitute of Medical Statistics and Informatics, Medical University of Innsbruck, Innsbruck, Austria.
Gudrun FeuchtnerDepartment of Radiology, Medical University Innsbruck, Innsbruck, Austria.ORCID 0000-0001-6755-4399
Gerlig WidmannDepartment of Radiology, Medical University Innsbruck, Innsbruck, Austria.
Christina DuftnerDepartment of Internal Medicine II, Medical University Innsbruck, Innsbruck, Austria.ORCID 0000-0003-3137-8834
Günter WeissDepartment of Internal Medicine II, Medical University Innsbruck, Innsbruck, Austria.ORCID 0000-0003-0709-2158
Andrea KlauserDepartment of Radiology, Medical University Innsbruck, Innsbruck, Austria.

Funding

Onkologie und Immunologie InnsbruckVerein zur Förderung von Hämatologie
6 · The paper itself

Abstract

objectiveTo determine the association of cardiovascular atherosclerotic plaque monosodium urate deposits with the occurrence of major cardiovascular events in gout and hyperuricemia patients.

methodsThis retrospective cohort study included patients with clinically suspicion of gout, who performed a dual energy computed tomography of the affected limb and thorax between 1 June 2012 and 5 December 2019. Clinical and laboratory parameters were retrieved from patients' charts. Established cardiovascular risk factors were evaluated. Medical history review identified the presence of major adverse cardiac events with a median follow-up time of 33 months (range 0-108 months) after the performed computed tomography scan.

resultsFull data sets were available for 189 patients: 131 (69.3%) gout patients, 40 (21.2%) hyperuricemia patients and 18 (9.5%) controls. Patients with cardiovascular monosodium urate deposits (n = 85/189, 45%) revealed increased serum acute phase reactants, uric acid levels and calcium scores in computed tomography compared with patients without cardiovascular monosodium urate deposits. Major adverse cardiac events were observed in 35 patients (18.5%) with a higher prevalence in those patients revealing cardiovascular monosodium urate deposits (n = 22/85, 25.9%) compared with those without cardiovascular monosodium urate deposits (n = 13/104, 12.5%, OR 2.4, P = 0.018).

conclusionThis is the first study demonstrating the higher hazard of major adverse cardiac events in patients with dual energy computed tomography-verified cardiovascular monosodium urate deposits. The higher prevalence of cardiac events in patients with cardiovascular monosodium urate deposits may facilitate risk stratification of gout patients, as classical cardiovascular risk scores or laboratory markers fail in their proper identification.

Indexed as

Cardiovascular DiseasesGoutHyperuricemiaPlaque, AtheroscleroticUric AcidAgedFemaleHeart Disease Risk FactorsHumansMaleMiddle AgedRetrospective StudiesTomography, X-Ray ComputedUric Acidcalcium scorecardiovascular riskDECTgouthyperuricemiaMACEmonosodium urate

Identifiers

PMID38652590
PMCPMC11879345

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.